THE USE OF SORAFENIB (NEXAVAR) IN TREATMENT OF PATIENT WITH DISSEMINATED PARATHYROID CANCER: A CASE REPORT

Parathyroid carcinoma (PC) is a rare neoplasm with a prevalence of only 0.005 % of all malignancies, and less than 1 % among patients with primary hyperparathyroidism. The diagnosis can be challenging due to the rarity of the disease, similarity of clinical features to parathyroid adenoma, and lack...

Full description

Bibliographic Details
Main Authors: V. A. Gorbunova, E. A. Pigarova, L. Ya. Rozhinskaya, I. A. Voronkova, Yu. A. Krupinova, G. S. Emel’yanova, L. S. Kruglova, S. V. Shiryaev, M. B. Dolgushin, M. E. Bilik, E. A. Kobyakova, D. V. Komov
Format: Article
Language:Russian
Published: ABV-press 2017-04-01
Series:Опухоли головы и шеи
Subjects:
Online Access:https://ogsh.abvpress.ru/jour/article/view/254
_version_ 1797876237756006400
author V. A. Gorbunova
E. A. Pigarova
L. Ya. Rozhinskaya
I. A. Voronkova
Yu. A. Krupinova
G. S. Emel’yanova
L. S. Kruglova
S. V. Shiryaev
M. B. Dolgushin
M. E. Bilik
E. A. Kobyakova
D. V. Komov
author_facet V. A. Gorbunova
E. A. Pigarova
L. Ya. Rozhinskaya
I. A. Voronkova
Yu. A. Krupinova
G. S. Emel’yanova
L. S. Kruglova
S. V. Shiryaev
M. B. Dolgushin
M. E. Bilik
E. A. Kobyakova
D. V. Komov
author_sort V. A. Gorbunova
collection DOAJ
description Parathyroid carcinoma (PC) is a rare neoplasm with a prevalence of only 0.005 % of all malignancies, and less than 1 % among patients with primary hyperparathyroidism. The diagnosis can be challenging due to the rarity of the disease, similarity of clinical features to parathyroid adenoma, and lack of reliable morphological signs of the tumor. For metastatic cancer of the parathyroid gland does not exist standard drug therapy due to the rare occurrence of this disease. Chemotherapy and radiotherapy failed to show any significant effect on the course of the disease. We report the case of a 27-year old woman with PC previously misdiagnosed as benign thyroid nodule and multiple lung metastases. After the immunohistochemical study and confirm of diagnosis PC the patient was treatment with multikinase inhibitor sorafenib successfully.
first_indexed 2024-04-10T01:58:57Z
format Article
id doaj.art-b2fd305b5ebd4dea8aed2c9bc3b0ae32
institution Directory Open Access Journal
issn 2222-1468
2411-4634
language Russian
last_indexed 2024-04-10T01:58:57Z
publishDate 2017-04-01
publisher ABV-press
record_format Article
series Опухоли головы и шеи
spelling doaj.art-b2fd305b5ebd4dea8aed2c9bc3b0ae322023-03-13T08:43:19ZrusABV-pressОпухоли головы и шеи2222-14682411-46342017-04-0164677210.17650/2222-1468-2016-6-4-67-72239THE USE OF SORAFENIB (NEXAVAR) IN TREATMENT OF PATIENT WITH DISSEMINATED PARATHYROID CANCER: A CASE REPORTV. A. Gorbunova0E. A. Pigarova1L. Ya. Rozhinskaya2I. A. Voronkova3Yu. A. Krupinova4G. S. Emel’yanova5L. S. Kruglova6S. V. Shiryaev7M. B. Dolgushin8M. E. Bilik9E. A. Kobyakova10D. V. Komov11Российский онкологический научный центр имени Н.Н. БлохинаЭндокринологический научный центрЭндокринологический научный центрЭндокринологический научный центрЭндокринологический научный центрМосковский государственный медико-стоматологический университет имени А.И. ЕвдокимоваЦентральная государственная медицинская академияРоссийский онкологический научный центр имени Н.Н. БлохинаРоссийский онкологический научный центр имени Н.Н. БлохинаРоссийский онкологический научный центр имени Н.Н. БлохинаРоссийский онкологический научный центр имени Н.Н. БлохинаРоссийский онкологический научный центр имени Н.Н. БлохинаParathyroid carcinoma (PC) is a rare neoplasm with a prevalence of only 0.005 % of all malignancies, and less than 1 % among patients with primary hyperparathyroidism. The diagnosis can be challenging due to the rarity of the disease, similarity of clinical features to parathyroid adenoma, and lack of reliable morphological signs of the tumor. For metastatic cancer of the parathyroid gland does not exist standard drug therapy due to the rare occurrence of this disease. Chemotherapy and radiotherapy failed to show any significant effect on the course of the disease. We report the case of a 27-year old woman with PC previously misdiagnosed as benign thyroid nodule and multiple lung metastases. After the immunohistochemical study and confirm of diagnosis PC the patient was treatment with multikinase inhibitor sorafenib successfully.https://ogsh.abvpress.ru/jour/article/view/254рак паращитовидных железметастазы в легкиепервичный гиперпаратиреозгиперкальциемиямультитаргетные ингибиторысорафениб
spellingShingle V. A. Gorbunova
E. A. Pigarova
L. Ya. Rozhinskaya
I. A. Voronkova
Yu. A. Krupinova
G. S. Emel’yanova
L. S. Kruglova
S. V. Shiryaev
M. B. Dolgushin
M. E. Bilik
E. A. Kobyakova
D. V. Komov
THE USE OF SORAFENIB (NEXAVAR) IN TREATMENT OF PATIENT WITH DISSEMINATED PARATHYROID CANCER: A CASE REPORT
Опухоли головы и шеи
рак паращитовидных желез
метастазы в легкие
первичный гиперпаратиреоз
гиперкальциемия
мультитаргетные ингибиторы
сорафениб
title THE USE OF SORAFENIB (NEXAVAR) IN TREATMENT OF PATIENT WITH DISSEMINATED PARATHYROID CANCER: A CASE REPORT
title_full THE USE OF SORAFENIB (NEXAVAR) IN TREATMENT OF PATIENT WITH DISSEMINATED PARATHYROID CANCER: A CASE REPORT
title_fullStr THE USE OF SORAFENIB (NEXAVAR) IN TREATMENT OF PATIENT WITH DISSEMINATED PARATHYROID CANCER: A CASE REPORT
title_full_unstemmed THE USE OF SORAFENIB (NEXAVAR) IN TREATMENT OF PATIENT WITH DISSEMINATED PARATHYROID CANCER: A CASE REPORT
title_short THE USE OF SORAFENIB (NEXAVAR) IN TREATMENT OF PATIENT WITH DISSEMINATED PARATHYROID CANCER: A CASE REPORT
title_sort use of sorafenib nexavar in treatment of patient with disseminated parathyroid cancer a case report
topic рак паращитовидных желез
метастазы в легкие
первичный гиперпаратиреоз
гиперкальциемия
мультитаргетные ингибиторы
сорафениб
url https://ogsh.abvpress.ru/jour/article/view/254
work_keys_str_mv AT vagorbunova theuseofsorafenibnexavarintreatmentofpatientwithdisseminatedparathyroidcanceracasereport
AT eapigarova theuseofsorafenibnexavarintreatmentofpatientwithdisseminatedparathyroidcanceracasereport
AT lyarozhinskaya theuseofsorafenibnexavarintreatmentofpatientwithdisseminatedparathyroidcanceracasereport
AT iavoronkova theuseofsorafenibnexavarintreatmentofpatientwithdisseminatedparathyroidcanceracasereport
AT yuakrupinova theuseofsorafenibnexavarintreatmentofpatientwithdisseminatedparathyroidcanceracasereport
AT gsemelyanova theuseofsorafenibnexavarintreatmentofpatientwithdisseminatedparathyroidcanceracasereport
AT lskruglova theuseofsorafenibnexavarintreatmentofpatientwithdisseminatedparathyroidcanceracasereport
AT svshiryaev theuseofsorafenibnexavarintreatmentofpatientwithdisseminatedparathyroidcanceracasereport
AT mbdolgushin theuseofsorafenibnexavarintreatmentofpatientwithdisseminatedparathyroidcanceracasereport
AT mebilik theuseofsorafenibnexavarintreatmentofpatientwithdisseminatedparathyroidcanceracasereport
AT eakobyakova theuseofsorafenibnexavarintreatmentofpatientwithdisseminatedparathyroidcanceracasereport
AT dvkomov theuseofsorafenibnexavarintreatmentofpatientwithdisseminatedparathyroidcanceracasereport
AT vagorbunova useofsorafenibnexavarintreatmentofpatientwithdisseminatedparathyroidcanceracasereport
AT eapigarova useofsorafenibnexavarintreatmentofpatientwithdisseminatedparathyroidcanceracasereport
AT lyarozhinskaya useofsorafenibnexavarintreatmentofpatientwithdisseminatedparathyroidcanceracasereport
AT iavoronkova useofsorafenibnexavarintreatmentofpatientwithdisseminatedparathyroidcanceracasereport
AT yuakrupinova useofsorafenibnexavarintreatmentofpatientwithdisseminatedparathyroidcanceracasereport
AT gsemelyanova useofsorafenibnexavarintreatmentofpatientwithdisseminatedparathyroidcanceracasereport
AT lskruglova useofsorafenibnexavarintreatmentofpatientwithdisseminatedparathyroidcanceracasereport
AT svshiryaev useofsorafenibnexavarintreatmentofpatientwithdisseminatedparathyroidcanceracasereport
AT mbdolgushin useofsorafenibnexavarintreatmentofpatientwithdisseminatedparathyroidcanceracasereport
AT mebilik useofsorafenibnexavarintreatmentofpatientwithdisseminatedparathyroidcanceracasereport
AT eakobyakova useofsorafenibnexavarintreatmentofpatientwithdisseminatedparathyroidcanceracasereport
AT dvkomov useofsorafenibnexavarintreatmentofpatientwithdisseminatedparathyroidcanceracasereport